Skip to main content

Table 2 The changes of lymphocyte subsets and plasma cytokines among PTC, TN and HP

From: Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma

Parameters

PTC

TN

HP

p1

p2

p3

Total T(%)

64.16 ± 8.31

61.95 ± 9.44

63.67 ± 8.23

0.142

0.752

0.294

CD3+CD4+(%)

36.66 ± 7.42

34.67 ± 6.31

38.79 ± 7.60

0.109

0.093

0.003

CD3+CD8+(%)

24.36 ± 7.67

23.97 ± 8.24

22.72 ± 6.70

0.763

0.223

0.388

CD4+HLA-DR+(%)

5.89 ± 4.06

4.75 ± 1.98

4.93 ± 2.57

0.036

0.085

0.758

CD8+ HLA-DR+(%)

12.84 ± 6.41

10.75 ± 4.72

8.62 ± 2.82

0.019

0.000

0.028

CD4+ CD25+(%)

16.74 ± 5.83

16.10 ± 6.04

13.62 ± 4.27

0.500

0.002

0.018

CD8+ CD38+(%)

9.34 ± 5.89

6.92 ± 4.19

6.57 ± 3.51

0.004

0.001

0.711

NK(%)

22.21 ± 7.62

22.27 ± 9.28

17.32 ± 5.80

0.962

0.000

0.001

B(%)

12.70 ± 4.49

13.30 ± 4.08

12.83 ± 2.81

0.379

0.849

0.530

IL-2(pg/ml)

0.65 ± 0.89

0.83 ± 0.40

0.64 ± 0.19

0.084

0.981

0.109

IL-4(pg/ml)

0.41 ± 1.61

0.18 ± 0.28

0.14 ± 0.27

0.219

0.150

0.824

IL-6(pg/ml)

2.79 ± 4.45

3.52 ± 12.55

2.82 ± 8.20

0.626

0.984

0.669

IL-10(pg/ml)

2.01 ± 1.97

2.38 ± 6.30

1.67 ± 0.87

0.557

0.614

0.314

TNF-α (pg/ml)

0.30 ± 0.32

0.20 ± 0.32

0.13 ± 0.16

0.069

0.001

0.162

IFN-γ (pg/ml)

1.12 ± 6.48

0.42 ± 1.34

0.70 ± 1.98

0.356

0.590

0.732

  1. p1: TPC and TN, p2:TPC and HP, p3:TN and HP